Van Eck Associates Corp Taro Pharmaceutical Industries LTD Transaction History

Van Eck Associates Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$40.97 - $43.33 $5,449 - $5,762	133 Added 4.68%	2,977 $126,000
Q4 2023 Feb 05, 2024	SELL	$32.77 - $42.31 $2,949 - $3,807	-90 Reduced 3.07%	2,844 $119,000
Q3 2023 Nov 08, 2023	BUY	$35.46 - $40.13 $6,631 - $7,504	187 Added 6.81%	2,934 $111,000
Q2 2023 Aug 03, 2023	SELL	$24.24 - $40.97 $460 - $778	-19 Reduced 0.69%	2,747 $104,000
Q1 2023 May 03, 2023	SELL	$23.0 - $31.59 $897 - $1,232	-39 Reduced 1.39%	2,766 $67,000
Q4 2022 Feb 08, 2023	SELL	$27.6 - $32.99 $276 - $329	-10 Reduced 0.36%	2,805 $81,000
Q3 2022 Oct 27, 2022	BUY	$28.74 - $39.9 $258 - $359	9 Added 0.32%	2,815 $84,000
Q2 2022 Aug 03, 2022	SELL	$35.0 - $43.59 $4,620 - $5,753	-132 Reduced 4.49%	2,806 $101,000
Q1 2022 May 10, 2022	BUY	$43.12 - $50.3 $689 - $804	16 Added 0.55%	2,938 $127,000
Q4 2021 Jan 26, 2022	SELL	$47.6 - $65.0 $10,043 - $13,715	-211 Reduced 6.73%	2,922 $146,000
Q3 2021 Nov 03, 2021	SELL	$62.34 - $73.38 $14,151 - $16,657	-227 Reduced 6.76%	3,133 $199,000
Q2 2021 Aug 10, 2021	BUY	$70.26 - $76.64 $1,967 - $2,145	28 Added 0.84%	3,360 $242,000
Q1 2021 May 13, 2021	BUY	$70.48 - $79.95 $234,839 - $266,393	3,332 New	3,332 $246,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

Stay updated on Van Eck Associates Corp with notifications on news.